Legato Capital Management LLC Sells 12,187 Shares of Aspen Aerogels, Inc. (NYSE:ASPN)

Legato Capital Management LLC lessened its holdings in Aspen Aerogels, Inc. (NYSE:ASPN) by 23.0% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 40,770 shares of the construction company’s stock after selling 12,187 shares during the quarter. Legato Capital Management LLC’s holdings in Aspen Aerogels were worth $484,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors have also recently bought and sold shares of ASPN. nVerses Capital LLC grew its stake in shares of Aspen Aerogels by 45.0% during the 3rd quarter. nVerses Capital LLC now owns 5,800 shares of the construction company’s stock worth $161,000 after acquiring an additional 1,800 shares during the period. Journey Strategic Wealth LLC bought a new position in shares of Aspen Aerogels during the 4th quarter worth $178,000. Ballentine Partners LLC grew its stake in shares of Aspen Aerogels by 19.2% during the 4th quarter. Ballentine Partners LLC now owns 15,914 shares of the construction company’s stock worth $189,000 after acquiring an additional 2,565 shares during the period. Quest Partners LLC grew its stake in shares of Aspen Aerogels by 263.3% during the 3rd quarter. Quest Partners LLC now owns 7,397 shares of the construction company’s stock worth $205,000 after acquiring an additional 5,361 shares during the period. Finally, Pursue Wealth Partners LLC bought a new position in shares of Aspen Aerogels during the 3rd quarter worth $222,000. Institutional investors own 97.64% of the company’s stock.

Analysts Set New Price Targets

Several research firms have recently weighed in on ASPN. StockNews.com upgraded Aspen Aerogels to a “sell” rating in a research note on Saturday, February 8th. Roth Mkm cut their target price on Aspen Aerogels from $22.00 to $16.00 and set a “buy” rating for the company in a research note on Friday. Craig Hallum cut their target price on Aspen Aerogels from $21.00 to $18.00 and set a “buy” rating for the company in a research note on Friday. Seaport Res Ptn downgraded Aspen Aerogels from a “strong-buy” rating to a “hold” rating in a research note on Wednesday. Finally, Canaccord Genuity Group cut their target price on Aspen Aerogels from $20.00 to $15.00 and set a “buy” rating for the company in a research note on Friday. One research analyst has rated the stock with a sell rating, one has assigned a hold rating, eight have given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $24.67.

Aspen Aerogels Stock Performance

NYSE:ASPN opened at $8.67 on Friday. The business’s 50-day moving average price is $12.27 and its two-hundred day moving average price is $18.56. Aspen Aerogels, Inc. has a twelve month low of $8.25 and a twelve month high of $33.15. The stock has a market cap of $711.02 million, a P/E ratio of 867.47 and a beta of 2.14. The company has a quick ratio of 2.48, a current ratio of 2.93 and a debt-to-equity ratio of 0.27.

Aspen Aerogels (NYSE:ASPN) last released its quarterly earnings results on Wednesday, February 12th. The construction company reported $0.15 earnings per share for the quarter, beating the consensus estimate of $0.04 by $0.11. Aspen Aerogels had a return on equity of 5.06% and a net margin of 0.36%. As a group, equities analysts predict that Aspen Aerogels, Inc. will post 0.12 EPS for the current fiscal year.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.